Weiss Multi-Strategy Advisers’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-18,241	Closed	-$1.7M	–	836
2021 Q4	$1.7M	Buy	18,241 +3,241	+22%	+$214K	0.04%	411
2021 Q3	$893K	Buy	+15,000	New	+$886K	0.02%	503
2020 Q3	–	Sell	-8,019	Closed	-$505K	–	721
2020 Q2	$505K	Buy	+8,019	New	+$441K	0.01%	465
2014 Q2	–	Sell	-3,404	Closed	-$214K	–	992
2014 Q1	$214K	Buy	3,404 +41	+1%	+$2.72K	﹤0.01%	902
2013 Q4	$197K	Buy	+3,363	New	+$176K	﹤0.01%	908

Weiss Multi-Strategy Advisers's ARNA Position: Q1 2022 in Review

Weiss Multi-Strategy Advisers sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 18,241 shares — an estimated $1.7M sold.

Weiss Multi-Strategy Advisers first reported a position in ARNA in Q4 2013 and held it in 5 quarters. The position peaked at $1.7M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Weiss Multi-Strategy Advisers reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 18,241 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.7M.
Weiss Multi-Strategy Advisers first reported a position in Arena Pharmaceuticals Inc in Q4 2013 and held it in 5 quarters.
Weiss Multi-Strategy Advisers's Arena Pharmaceuticals Inc position peaked at $1.7M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2022, filed 16 May 2022.